These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3570023)
1. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens]. Grodecka-Gazdecka S; Baron J Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023 [No Abstract] [Full Text] [Related]
2. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513 [TBL] [Abstract][Full Text] [Related]
3. [Changes in the levels of sex hormone-binding globulin, estradiol and testosterone in the serum of women with breast cancer during various types of hormone therapy]. Chwalisz K; Grodecka-Gazdecka S; Baron J Nowotwory; 1987; 37(1):16-24. PubMed ID: 3628027 [No Abstract] [Full Text] [Related]
4. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer]. Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535 [No Abstract] [Full Text] [Related]
5. [Concentration of selected sex hormones and SHBG in the serum of women with breast cancer treated with antiestrogens and (or) cytostatic agents]. Grodecka-Gazdecka S; Kociałkowski K Nowotwory; 1990; 40(1):5-11. PubMed ID: 2356147 [TBL] [Abstract][Full Text] [Related]
6. Serum hormone levels in British and rural Chinese females. Wang DY; Key TJ; Pike MC; Boreham J; Chen J Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S41-5. PubMed ID: 1873556 [TBL] [Abstract][Full Text] [Related]
7. [Prolactin and estradiol levels during hormone therapy of breast cancer]. Grodecka-Gazdecka S; Chwalisz K; Baron J Ginekol Pol; 1985 Apr; 56(4):195-201. PubMed ID: 4043797 [No Abstract] [Full Text] [Related]
8. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315 [TBL] [Abstract][Full Text] [Related]
9. Sex hormones in postmenopausal women with breast cancer on tamoxifen. Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950 [TBL] [Abstract][Full Text] [Related]
10. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S Oncology; 1986; 43(1):7-11. PubMed ID: 3079899 [TBL] [Abstract][Full Text] [Related]
11. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer. Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175 [TBL] [Abstract][Full Text] [Related]
12. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer. McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323 [No Abstract] [Full Text] [Related]
13. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging]. Kamatsuki S Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181 [No Abstract] [Full Text] [Related]
14. Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen. Bhatavdekar JM; Shah NG; Patel DD; Karelia NH; Trivedi SN; Vora HH; Ghosh N; Giri DD; Balar DB Neoplasma; 1992; 39(2):123-7. PubMed ID: 1528310 [TBL] [Abstract][Full Text] [Related]
15. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Secreto G; Recchione C; Fariselli G; Di Pietro S Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901 [TBL] [Abstract][Full Text] [Related]
16. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer. Rannikko S; Adlercreutz H Prostate; 1983; 4(3):223-9. PubMed ID: 6189106 [TBL] [Abstract][Full Text] [Related]
17. Influence of radical prostatectomy on serum hormone levels. Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896 [TBL] [Abstract][Full Text] [Related]
18. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients. Ellmén J; Hakulinen P; Partanen A; Hayes DF Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654 [TBL] [Abstract][Full Text] [Related]
19. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients. Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248 [TBL] [Abstract][Full Text] [Related]
20. Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients. Baumgart J; Nilsson K; Stavreus Evers A; Kunovac Kallak T; Kushnir MM; Bergquist J; Sundström Poromaa I Climacteric; 2014 Feb; 17(1):48-54. PubMed ID: 23647561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]